LCAT and metabolic dysfunction-associated steatotic liver disease: Altogether, our data may suggest that the lower cholesterol efflux in metabolic NAFLD could be attributed to the reduction of pre-β HDL particles and to the lower LCAT activity, resulting into increased unesterified cholesterol and suppressed formation of mature α-HDL.